High expression levels of LSM2, LSM3, LSM4, LSM5, LSM6, LSM7, LSM8, LSM11, and LSM14A were associated with shorter OS of GC patients undergoing 5-FU based chemotherapy, while LSM12 was on the contrary. This evidence concerns the gene LSM2 and gastric cancer.